TGA
Change on the agenda
Sildenafil, cannabidiol and ibuprofen among those to be considered for rescheduling Australia’s medicine scheduling body is to consider another request to have sildenafil (Viagra) rescheduled. The June joint meeting of …
Watch what you’re saying
Regulators warn HCPs to stick to the facts on COVID-19 advertising and information Health professionals are being warned to be careful with advertising and information they provide about COVID-19. A …
Reports hand sanitiser sold for five times the normal price
First hand sanitiser ‘round table’ held in Australia looks at costs and availability, while TGA cuts legislative red tape on manufacturing to facilitate urgent and continued supply Last Friday, the …
Don’t listen to ‘medical medium’ say docs
Stakeholders have called on the general public to get their information about COVID-19 from reputable sources, as the TGA warns on inappropriate advertising The TGA says that it has identified …
Equity goes out the window?
Claims that rural pharmacies have been experiencing shortages after an “unprecedented run” on PBS medicines by large groups The Rural Pharmacy Network Australia (RPNA) has called for an investigation into …
An unclear situation
No COVID-19 related medicine shortages yet, regulators say, but reports surface of rural supply issues The TGA is continuing to advise consumers against the stockpiling of medicines, saying that there …
Don’t stockpile meds: TGA
The TGA has issued new advice telling Australians that there’s no need to stockpile medicines, as it could cause access problems for others On Tuesday, the Therapeutic Goods Administration said …
Out of stock
Massive increase in reports of medicine shortages following introduction of mandatory reporting The number of notifications of medicines shortages has jumped massively following the introduction of mandatory reporting in January …
IV infusions under fire
Complaint filed to HCCC and TGA over therapeutic claims for IV therapy made by Australian clinics A number of Australian businesses are making therapeutic claims for IV therapy that a …
Confusion reigns over EpiPen availability
Patient frustration at difficulty accessing EpiPens is understandable – but it’s unfair to call pharmacy “complacent,” says a leading pharmacist Allergy and Anaphylaxis Australia chief executive Maria Said has told …
Check Palexia strips: TGA
A labelling problem has seen Seqirus undertake a product defect correction over one batch of Palexia The TGA has advised consumers and health professionals that in consultation with the TGA, …
Taking the right path
As new laws regarding the prescribing, dispensing and cultivation of medicinal cannabis come into play, pharmacists have an essential role in ensuring patients receive the right advice Since legislative changes …